{
  "run_id": "RUN_20260205_073751_f71574fffb78",
  "timestamp": "2026-02-05T09:08:10.036866",
  "document": "Dejerine.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/NLP4RARE/dev/Dejerine.pdf",
  "pipeline_version": "0.8",
  "total_candidates": 2,
  "total_validated": 2,
  "total_rejected": 0,
  "total_investigational": 0,
  "drugs": [
    {
      "matched_text": "carbon dioxide",
      "preferred_name": "carbon dioxide",
      "brand_name": "CARBON DIOXIDE, USP",
      "compound_id": null,
      "confidence": 0.7,
      "is_investigational": false,
      "drug_class": "Radiographic Contrast Agent",
      "mechanism": null,
      "development_phase": null,
      "sponsor": null,
      "conditions": [],
      "nct_id": null,
      "dosage_form": "GAS",
      "route": "INHALATION",
      "marketing_status": "Prescription",
      "codes": {
        "rxcui": null,
        "mesh": "D002245",
        "ndc": null,
        "drugbank": null,
        "unii": null
      },
      "all_identifiers": [
        {
          "system": "FDA_NDA",
          "code": "NDA205815",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D002245",
          "display": "Carbon Dioxide"
        }
      ],
      "context": "ak as the condition worsens. Individuals with DSS may have respiratory insufficiency, meaning they do not take in enough oxygen or breathe out enough carbon dioxide. Mild vision difficulties may also occur. Other symptoms include pain, loss of heat sensitivity, absence of reflexes, muscle loss (atrophy) of leg mu",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_fda_approved_drugs.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Dry Ice",
        "carboxyl radical",
        "carbon dioxide reduction factor"
      ],
      "pubtator_normalized_name": "Carbon Dioxide",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "carbon",
      "preferred_name": "Carbon",
      "brand_name": null,
      "compound_id": null,
      "confidence": 0.7,
      "is_investigational": false,
      "drug_class": null,
      "mechanism": null,
      "development_phase": null,
      "sponsor": null,
      "conditions": [],
      "nct_id": null,
      "dosage_form": null,
      "route": null,
      "marketing_status": null,
      "codes": {
        "rxcui": null,
        "mesh": "D002245",
        "ndc": null,
        "drugbank": null,
        "unii": null
      },
      "all_identifiers": [
        {
          "system": "RxCUI",
          "code": "2031",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D002245",
          "display": "Carbon Dioxide"
        }
      ],
      "context": "ak as the condition worsens. Individuals with DSS may have respiratory insufficiency, meaning they do not take in enough oxygen or breathe out enough carbon dioxide. Mild vision difficulties may also occur. Other symptoms include pain, loss of heat sensitivity, absence of reflexes, muscle loss (atrophy) o",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_lexicon_drug.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Carbon",
        "Carbon Monoxide",
        "Carbon-13"
      ],
      "pubtator_normalized_name": "Carbon Dioxide",
      "enrichment_source": "pubtator3"
    }
  ]
}